| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/29/1992 | EP0481994A1 Metallo-organic cobalt compounds and uses thereof |
| 04/28/1992 | US5108994 Antiviral purine derivatives |
| 04/28/1992 | US5108743 Administering polypeptide having human gamma interferon activity |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299575C Phosphate ester derivatives, and their use as anti-cancer agents |
| 04/23/1992 | CA2053772A1 Benzolactam analogs as antagonists of cck |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481214A1 Prodrugs of phosphonates |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0480950A1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 04/22/1992 | EP0480918A1 Reduced size lhrh analogs |
| 04/22/1992 | CN1016345B Process for preparing anti-tumour platinum complexes |
| 04/22/1992 | CN1016341B Novel spergualin-related compounds and process for producing the same |
| 04/21/1992 | US5107007 Antitumor agents |
| 04/21/1992 | US5107005 Process to obtain new mixed copper aminoactidate complexes from phenylate phenathrolines to be used as anticancerigenic agents |
| 04/21/1992 | US5106981 Skin disorders |
| 04/21/1992 | US5106955 Process for preparation of antibody conjugates |
| 04/21/1992 | US5106951 Antineoplastic anthracyline agents intercalated with two aromatic side chains or an oligopeptide and covalently attached to an antibody |
| 04/21/1992 | US5106864 Antitumor substance be-13793c |
| 04/21/1992 | US5106858 For disfunction of heart, brain, lung or kidney |
| 04/21/1992 | US5106840 Method of preparing n-oxo-tetrahydro-beta-carbolines |
| 04/21/1992 | US5106616 Administration of acemannan |
| 04/21/1992 | CA1299179C Platinum complexes with one radiosensitizing ligand |
| 04/21/1992 | CA1299169C Steroids having a spiro cycle in position 17, their process and intermediaries,their use as medications and the pharmaceutical preparations containing such |
| 04/21/1992 | CA1299100C Extracts of nerium species, methods of preparation and use therefor |
| 04/20/1992 | WO1992006687A1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 04/19/1992 | WO1992006995A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2091771A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/16/1992 | WO1992006193A1 Antibodies directed against cd3 |
| 04/16/1992 | WO1992006106A1 A plant protein useful for treating tumors and hiv infection |
| 04/16/1992 | WO1992005805A1 Synergism of tnf and il-4 |
| 04/16/1992 | WO1992005803A1 Self-assembling ion pair drugs |
| 04/16/1992 | WO1992005785A1 Water soluble camptothecin analogues, processes and methods |
| 04/16/1992 | WO1992004015A3 Regulation of t-cell proliferation via a novel 5ht1a receptor |
| 04/16/1992 | CA2093800A1 Plant protein useful for treating tumors and hiv infection |
| 04/15/1992 | EP0480440A1 Monoclonal antibody against melanoma |
| 04/15/1992 | EP0480338A1 Diterpene compound and process for producing the same |
| 04/15/1992 | EP0480315A2 Use of a retinoid |
| 04/15/1992 | EP0480077A1 Process for obtaining carnosic acid |
| 04/15/1992 | EP0479951A1 Bis-acyloxymethyl derivatives |
| 04/14/1992 | US5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
| 04/14/1992 | US5104896 Carboplatin composition |
| 04/14/1992 | US5104895 Platinum(ii) complexes, their preparation and use as anti-tumor agents |
| 04/14/1992 | US5104653 Use of human interferon-beta for stimulation of erythropoiesis |
| 04/14/1992 | CA1298833C Glycerol derivatives, their production and use |
| 04/13/1992 | WO1992007271A1 Mouse monoclonal antibodies |
| 04/13/1992 | WO1992007081A2 A monoclonal antibody |
| 04/13/1992 | CA2052686A1 Use of a retinoid |
| 04/11/1992 | WO1992007072A1 Method of inhibiting transcription utilizing nuclear receptors |
| 04/11/1992 | CA2093811A1 Method of inhibiting transcription utilizing nuclear receptors |
| 04/10/1992 | WO1992006092A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 04/10/1992 | WO1992006084A1 Chromans and thiochromans with retinoid-like activity |
| 04/10/1992 | CA2092178A1 Chromans and thiochromans with retinoid-like activity |
| 04/10/1992 | CA2091763A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 04/08/1992 | EP0479071A2 Polypeptide |
| 04/08/1992 | EP0478708A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 04/08/1992 | EP0478545A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 04/08/1992 | EP0345263B1 Iron-releasing monokine |
| 04/08/1992 | EP0282507B1 Discorhabdin compositions and their methods of use |
| 04/08/1992 | CN1016174B Preparation of pyrido (2,3-d) pyrimidine derivatives |
| 04/07/1992 | US5102988 Of human fibronectin |
| 04/02/1992 | WO1992006068A1 High affinity tamoxifen derivatives and uses thereof |
| 04/02/1992 | WO1992005262A1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/02/1992 | WO1992005256A1 Natural killer stimulatory factor |
| 04/02/1992 | WO1992005197A1 Purification of cytokeratin fragments |
| 04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
| 04/02/1992 | WO1992004901A1 Uracil reductase inactivators |
| 04/02/1992 | CA2390654A1 Uracil reductase inactivators |
| 04/02/1992 | CA2092996A1 High affinity tamoxifen derivatives and uses thereof |
| 04/01/1992 | EP0478416A1 Use of triazine- and pyrimidine derivatives for the preparation of medicaments reversing the resistance to anticancer and antimalarial agents |
| 04/01/1992 | EP0478101A2 Therapeutic use of peptides having thrombospondin-like activity |
| 04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
| 04/01/1992 | EP0477195A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
| 03/31/1992 | US5101072 Anticancer agents, trypanocides |
| 03/31/1992 | US5101038 Antitumor antibiotic |
| 03/31/1992 | US5100885 Copper radiosensitizers |
| 03/31/1992 | US5100881 N-(23-vincristinoyl) and n-(5'-noranhydro-23-vinblastinoyl) compounds of 1-aminomethylphosphonic acid useful for the treatment of neoplastic diseases |
| 03/31/1992 | US5100873 Bombesin antagonist, anticancer agents, oligopeptides |
| 03/31/1992 | CA1298309C Benzocycloheptene derivatives |
| 03/31/1992 | CA1298304C Benzoic benzopyranyl and benzothiopyranyl compounds, process for their preparation and their use in cosmetics |
| 03/28/1992 | WO1992005804A1 Chelating agents |
| 03/28/1992 | CA2092434A1 Chelating agents |
| 03/28/1992 | CA2052441A1 Use of triazine and pyrimidine derivatives to obtain drugs which reverse anti-cancer and anti-malaria drug resistance |
| 03/26/1992 | WO1992005173A1 Substituted tricyclic compounds |
| 03/26/1992 | CA2091690A1 Substituted tricyclic compounds |
| 03/25/1992 | EP0477141A1 Heteroarylmethylbenzols aromatase inhibitors |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/25/1992 | EP0476944A1 Aromatase inhibiting 4(5)-imidazoles |
| 03/25/1992 | EP0476711A2 Use of 5-fluorouracil for the treatment of AIDS |
| 03/25/1992 | EP0476011A1 Photosensitizing diels-alder porphyrin derivatives |
| 03/25/1992 | CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 03/24/1992 | US5098935 Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof |
| 03/24/1992 | US5098923 Aromatase inhibiting 4(5)-imidazoles |
| 03/24/1992 | US5098921 Antitumor agents |
| 03/24/1992 | US5098911 Hemihydrate of 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride |
| 03/24/1992 | US5098907 Nonionic surfactants |
| 03/24/1992 | US5098895 Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions |
| 03/24/1992 | US5098535 Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
| 03/24/1992 | CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino|-5, 8-dihydroxyanthraquinones |
| 03/22/1992 | WO1992005266A2 Packaging cells |